Tony Byrne Orthopaedic Sarcoma Surgical Research Support Fund
ANZSA is offering an orthopaedic sarcoma research grant funded by the Tony Byrne Orthopaedic Sarcoma Surgical Research Support Fund (OSSRSF). One grant of up to $10,000 is offered to support high quality orthopaedic oncology research led or supervised by orthopaedic surgeons that improves the care and outcomes of patients with bone and soft tissue tumours. The grant (commencement date 1 July 2027), is offered for 12 months at the end of which, the proposed work must be completed.
The grant is intended to assist orthopaedic surgeons and orthopaedic trainees in generating, analysing, publishing and disseminating research that advances the care of patients with bone and soft tissue tumours.
Objectives
- Increase the quantity and quality of research by orthopaedic oncology in Australia and New Zealand
- Support orthopaedic surgeons undertaking clinically relevant research across the continuum of musculoskeletal oncology, including basic science, translational, clinical, rehabilitation and health services research
- Facilitate collaboration between surgical centres and investigators
- Improve publication rates of orthopaedic oncology research
- Promote evidence-based clinical practice
- Support early-career researchers and trainees
- Encourage multicentre and international research initiatives
Scope of Funding
Projects led by orthopaedic surgeons may include, but are not limited to:
- Surgical research and innovation
- Translational or laboratory-based research (e.g. tumour biology or tumour microenvironment studies)
- Epidemiological research
- Rehabilitation and quality-of-life research
- Health services research, including referral pathways, service delivery and access to care
- Registry-based research
- Systematic reviews
- Multicentre collaborative studies
Eligibility
ANZSA members who are:
- Orthopaedic surgeons with an interest in musculoskeletal oncology or
- Orthopaedic trainees supervised by an ANZSA member orthopaedic surgeon or
- Multidisciplinary investigators where the Principal Investigator or supervising investigator is an ANZSA member orthopaedic oncology surgeon.
Expectation
The grant recipient must:
- Be a member of ANZSA at the time of application submission
- Report at regular intervals (6 months, 12 months and at completion of the project) to ANZSA
- Present findings at ANZSA scientific meetings
- Acknowledge ANZSA and the Tony Byrne Orthopaedic Sarcoma Surgical Research Support Fund in all presentations and publications
Application
The grant is awarded for direct research costs – salary support is not allowed. All applicants should include a budget with their application. Applications will be assessed against the following criteria:
- Clinical relevance
- Scientific merit
- Feasability
- Team capability
- Benefit to orthopaedic surgical oncology community
Applications open on 4 November 2026 and close at 5pm on 29 January 2027.
